To access this element change to forms mode OFF
Grant Award View - GA83301
The RESELECT Trial
GA ID:
GA83301
Agency:
Department of Health and Aged Care
Approval Date:
13-May-2020
Publish Date:
11-Jun-2020
Category:
Medical Research
Grant Term:
10-Jun-2020 to 7-Dec-2024
Value (AUD):
$1,122,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
The RESELECT Trial
Purpose:
The RESELECT trial – Rescuing bone marrow function in patients with relapsed acquired Aplastic Anaemia and/or bone marrow failure post allogeneic stem Cell Transplantation is an interventional clinical trial that has the potential to improve both quality and quantity of life for Australian patients with very high risk bone marrow failure. The RESELECT trial will provide patients immediate access to novel therapies, whilst simultaneously developing a platform for the delivery of a pipeline of innovative treatments, including cutting edge cellular and gene therapies, for subsequent patient cohorts. It is an opportunity to make significant impact on the lives of Australian patients and families affected with Bone Marrow Failure Syndromes.
Internal Reference ID:
EPCD000012
Selection Process:
Closed Non-Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
M RIEWOLDT HOLDINGS LIMITED
Recipient ABN:
20 613 016 765
Grant Recipient Location
Suburb:
Huntingdale
Town/City:
Huntingdale
Postcode:
3166
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3052
Country:
AUSTRALIA